Hans W Nijman

16PUBLICATIONS
79CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsTumour immunologyDisease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Aug 29, 2025
Spatiotemporal Immune Landscape and Long-term Immune Memory in POLE-Mutant Endometrial Cancer at the Single-Cell Level.

Koen Brummel, Marta Requesens, Nienke van Rooij

|Jun 13, 2025
The Prognostic Value of FOXL2 Mutant Circulating Tumor DNA in Adult Granulosa Cell Tumor Patients.

Geertruid J Brink, Nizar Hami, Hans W Nijman

|Apr 01, 2025
Radical hysterectomy or chemoradiotherapy for clinically early-stage cervical cancer with suspicious lymph nodes on imaging: a retrospective cohort study.

Ester P Olthof, Hans H B Wenzel, Marissa C van Maaren

|Jan 24, 2025
Vvax001, a Therapeutic Vaccine, for Patients with HPV16-Positive High-grade Cervical Intraepithelial Neoplasia: A Phase II Trial.

Anneke L Eerkens, Martha D Esajas, Koen Brummel

|Nov 27, 2024
Response to Systemic Therapies in Patient-Derived Cell Lines from Primary and Recurrent Adult Granulosa Cell Tumors.

Geertruid J Brink, Nizar Hami, Sander Mertens

|Sep 03, 2024
Neoadjuvant immune checkpoint blockade in women with mismatch repair deficient endometrial cancer: a phase I study.

Anneke L Eerkens, Koen Brummel, Annegé Vledder

Pageof 3

Frequent Collaborators

5 joint publications

Marco de Bruyn

4 joint publications

Anneke L Eerkens

3 joint publications

Toos Daemen

3 joint publications

Koen Brummel